baber/WOPTO huggingface dataset:
Patent JP-H09500578-A (JP)
IPC: A23L7/109
Filed: 1995-04-20
Abstract: PCT No. PCT/CH95/00084 Sec. 371 Date Dec. 1, 1995 Sec. 102(e) Date Dec. 1, 1995 PCT Filed Apr. 20, 1995 PCT Pub. No. WO95/31275 PCT Pub. Date Nov. 23, 1995A process and an apparatus for cleaning pasta presses, particularly for the "in situ" cleaning of the screws of screw-type machines, kneader mixers and the like in the pasta industry. This is effected without dismantling the machine by conveying cleaning liquids through the screw-type machines which are closed in liquid-tight manner. The cleaning liquids are preferably recycled and filtered.
Patent JP-2001508062-A (JP)
Title: 医薬品の経皮浸透用ヒドロアルコール組成物
IPC: A61K47/14
Filed: 1997-12-23
Abstract: (57)【要約】
医薬品の経皮的デリバリーの促進に有用なヒドロアルコール組成物、調製方法、経皮的デリバリー系、医薬品デリバリー方法が提供される。この組成物は、重量比が少なくとも約20:80の低級アルコールおよび水と、医薬品と、乳化剤系とを含む。
Patent JP-2000508059-A (JP)
Title: 薄膜構造を備えた磁界感応センサ及びセンサの使用方法
IPC: G01R33/09
Filed: 1997-02-28
Abstract: (57)【要約】
外部磁界内に配置される磁界感応センサ（Ｓ）は、磁界感度に関する材料異方性を備えた少なくとも１つの測定層を持つ薄膜構造（３）を有する。この薄膜構造（３）は、その場合、特に測定層（３ｅ）とすることもできる少なくとも１つの軟磁性層（３ｅ’）を備える。この軟磁性層（３ｅ’）に対して、測定層（３ｅ）に垂直な回転軸に関する対称性個数が測定層の材料異方性の対応する対称性の個数に関連して選ばれている予め定められた対称形状が選ばれるものとする。センサの磁界に対する応答特性の形状はこのようにして調整可能である。
Patent JP-H11503872-A (JP)
Title: 水素化ニッケル金属バッテリー用の改良電気化学水素貯蔵合金
IPC: H01M10/30
Filed: 1996-04-04
Abstract: (57)【要約】
（ベース合金） a Ｃｏ b Ｍｎ c Ｆｅ d Ｓｎ e （ここで、ベース合金は０．１〜６０原子％のＴｉ、０．１〜４０原子％のＺｒ、０〜６０原子％のＶ、０．１〜５７原子％のＮｉ、および０〜５６原子％のＣｒからなり；ｂは０〜７．５原子％；ｃは１３〜１７原子％；ｄは０〜３．５原子％；ｅは０〜１．５原子％；およびａ＋ｂ＋ｃ＋ｄ＋ｅ＝１００原子％である。）からなる不規則電気化学水素貯蔵合金。
Patent JP-2000508571-A (JP)
Title: 自転車用シューズ
IPC: A43B5/14
Filed: 1998-02-05
Abstract: (57)【要約】
本発明は、甲皮を支持する外部フレームであって、該フレームが前方部分、踵部分および踵部分と前方部分とを連結し、ねじり可撓性のある底面部材を有し、この踵部分が、漕ぎ手の脚部の垂直に平面から離れる動きに反応して、前方部分に対して軸方向に回転可能であるフレームと；前方部分と踵部分との間に延在する内側面部分と；前方部分と踵部分との間に延在し、踵部分の前方部分に対する水平および垂直な転位に対する抵抗性がある外側面部材とを備えている自転車用シューズに関する。
Patent JP-2000507158-A (JP)
Title: 殺生物剤活性の増強方法
IPC: C09K23/10
Filed: 1997-10-30
Abstract: (57)【要約】
殺生物化合物の活性を増強して水系における微生物の増殖を制御するための処理法であって、有効量のアルキルスルホスクシネート界面活性剤を該化合物に加えることからなる処理法が開示されている。
Patent JP-2001515651-A (JP)
Title: 性能が向上した電気通信コネクタ
IPC: H01R13/658
Filed: 1998-09-14
Abstract: (57)【要約】
プラグ（１００）およびアウトレット（３００）から成るコネクタであり、接続時には、各々が一対の接触子（１６０、３５０）を収納する四つのシールドされたカドラントを形成する。プラグ内のシールド部材（１３２，１３４）は重なり合い、アウトレット内のシールド部材（３３６，３３０）は重なり合う。さらに接続時には、アウトレット内のシールド部材（３３６，３３０）は、プラグ内の隣接するシールド部材に重なる。各シールド部材接合部においてシールド部材を重ねることによって、シールディングが向上されクロストークが低減される。
Patent JP-H11513963-A (JP)
Title: エレベータ設置方法および装置
IPC: B66B7/00
Filed: 1998-03-06
Abstract: (57)【要約】
本発明はエレベータのシャフト装置の測深・設置に用いる方法および装置に関するものである。測深ジグ（22）をエレベータシャフトの上部に最上階（11）から取り付け、下げ振り糸（43）を測深ジグに最上階（11）から取り付け、測深ジグ（22）に取り付けられた下げ振り糸（43）を使用してシャフト装置（28）を位置決めし、それからシャフト装置（28）を適所に固定する。本発明の装置はエレベータシャフトに固定可能な支持要素（41）と、支持要素（41）に取り付け可能で実質的に最上階（11）から据え付け可能な測深ジグ（22）と、測深ジグ（22）から懸垂でき、エレベータシャフト（２）内で測深ジグの下へ伸びる下げ振り糸（43）とを含む。
Patent JP-2001514563-A (JP)
Title: 外科手術用クリップおよびクランプ
IPC: A61B17/122
Filed: 1998-03-10
Abstract: (57)【要約】
外科手術用クランプ（１２）は、近位端に締め付け用ジョー（１５、２１）を有し、遠位端に操作用ハンドル組立体を有する軸（１６）を包含する。軸は、ハンドル組立体（１４）の操作前に使用者によって所望の形状に動かされ、ハンドル組立体（１４）およびジョー（１８、２１）の捜査中に所望の形状を保持する特性を有する。制御要素が、屈曲可能な要素に対して配置してあり、これが軸の近位端でハンドル組立体（１４）から操作して、軸（１６）の遠位端でジョー（１８、２１）を相対的に移動させることができる。関連した方法は、クランプ（１２）の操作前に軸（１６）を所望の形状に曲げ、クランプ（１２）の操作中に軸（１６）をほぼ所望の形状に維持する段階を包含する。
Patent JP-H11509682-A (JP)
Title: 低圧水銀放電ランプ
IPC: H01J61/20
Filed: 1997-05-05
Abstract: (57)【要約】
本発明による低圧水銀放電ランプには、水銀及び希ガスを収容する光透過性放電容器（１０）と、この放電容器内に放電を維持する手段（２０）とが設けられている。この放電容器内には、アマルガム（３１）を支持する金属ホルダ（３０）が配置されている。この金属ホルダ（３０）は軸線（３２）を中心として曲げられた金属プレート（３３）であり、互いの方向に接近するように曲げられたこの金属プレートの部分（３４ａ，３４ｂ）がスロット（３５）を画成し、この金属ホルダはその端部（３６）で押しつぶされ、アマルガム（３１）が金属ホルダの内面上でこの金属ホルダを被覆している。この金属ホルダの製造は簡単となる。
Patent JP-2000512232-A (JP)
Title: 回路板用押出し加工芯材積層体
IPC: H05K3/02
Filed: 1998-05-01
Abstract: (57)【要約】
連続工程による回路板積層体(10)の製造方法は、押出し加工した積層体芯材(12)を利用している。繊維質材料、微小球又は溶融シリカ、触媒、及び熱硬化性樹脂から成る流れが押出し機に供給され、芯材が薄膜状に押出し加工される；外層(18,19)が押出し加工された芯材に貼り付けられる場合がある。
Patent JP-2000515426-A (JP)
Title: ルテニウム触媒及び弱配位基質の不斉水素添加におけるその使用
IPC: C07C67/283
Filed: 1998-05-19
Abstract: (57)【要約】
２座配位ホスフィンリガンドを有するルテニウム（ＩＩ）触媒が記載されており、この触媒は、好適なＲｕ（ＩＩ）錯体及び２座配位ジホスフィンリガンドの等モル量を、式ＨＸ［式中、Ｘは非−配位陰イオンである］の酸で処理することより成る方法によって得られ、前記の酸は、Ｒｕ（ＩＩ）錯体１モル当たり、１モル当量の比率で使用され、この処理は、非−配位又は弱配位媒体中で、酸素不含の雰囲気下で実施される。前記の触媒は、立体配置（＋）−（１Ｒ）−シスを有する、Hedione（登録商標）の有利な異性体、及び高度に立体障害された炭素−炭素二重結合を有する多くの他の基質の製造に有用である。
Patent MX-152752-A (MX)
Inventor: CAMPBELL FRANK JR
IPC: F27D3/02
Filed: 1980-09-09
Abstract: A water-cooled skid pipe suitable for supporting metal shapes such as billets, blooms and slabs in a metallurgical reheat furnace. The skid pipe has a base member, a pair of upwardly extending, converging side members and an apex member connecting the uppermost portions of the side members, all such members defining a passageway therethrough suitable for conducting a fluid. A pair of shoulders extend outwardly of the junction of each side member and the apex member, which shoulders and apex member receive the slag which is deposited by the metal shapes onto the skid pipe and prevent the slag from migrating into the seam between the skid pipe and a surrounding insulator. The shoulders further protect any suitable insulator, which can be applied around the base member and converging side members, from direct contact by the metal shape thereby substantially minimizing the impact of the metal shape upon the insulator. The metal shape can be supported directly by the apex member or by a skid member secured atop the apex member. The invention can be used outside a furnace as an improved structural support member.
Patent MX-161590-A (MX)
Inventor: FRANKE WALTER
IPC: B65G17/12
Filed: 1984-10-19
Abstract: A continuous conveyor is provided having horizontal and vertical runs wherein articulated carrier members are combined with spacing members so that on horizontal runs a continuous belt is formed without gaps and wherein the spacer members form a supporting lip for the horizontal members during vertical runs.
Patent NZ-194674-A (NZ)
Title: 14-amino-10,13-dimethyl-3-substituted-gonanes
Inventor: JARREAU F-X
IPC: C07J41/00
Filed: 1980-08-14
Abstract: The invention relates to medicinally useful steroid derivatives, particularly amino-14 steroids substituted at the 17-position by a functional group represented by the general formula:    <IMAGE>  (I) wherein R1 is a hydroxy, hydroxyalkyl, alkoxy, acyloxy, carboxy or carbalkoxy group, or a hydrogen atom, and R2 is a hydroxy, alkoxy, or acyloxy group. These amino-14 steroids are prepared from the corresponding hydroxy-14 steroids, by the action of hydrazoic acid in the presence of boron trifluoride etherate to form the azido-14 derivative which is reduced.
Patent NZ-205559-A (NZ)
Title: Leukotriene antagonists, pharmaceutical compositions, and intermediates
Inventor: BELANGER P C
IPC: C07C59/90
Filed: 1983-09-12
Abstract: Compounds of the formulae: <CHEM> and their pharmaceutically acceptable (including acid-addition) salts, which are novel, are antagonists of leukotrienes of C4, D4 and E4, the slow reacting substance of anaphylaxis. They can be made into pharmaceutical compositions by incorporating them in a pharmaceutical carrier. In the formulae, each R is H, OH, SH, C1-6 alkyl, C2-6 alkenyl, CF3, C1-6 alkoxy, C1-6 alkythio, phenyl, phenyl having C1-3 alkyl or halogen substitution, phen (C2-4 alkyl), halogen, amino, N(R4)2, COOR4 or CH2OR4 where R4 is H or C1-6 alkyl, formyl, CN, CF3S or NO2; each R<1> is R4; OR4; COOR4; N(R4)2; SR4; CH2OR4 or CHO; or together R min  and R min  are O, CH2 or <CHEM>  Y is oxyge, sulfur, sulfoxide, sulfone,    @ = NR11,  = NR12, = N - CO - R13 or - N - CN, where R11 is C1-4 alkyl, R12 is H or C1-4 alkyl and R13 is C1-4 alkyl or C1-4 alkoxy;  Y min  is Y, -CH2- or    - @ -;  each R1 is hydrogen or C1-3 alkyl;  each m is an integer from 0 to 6; <CHEM>  where Z is O, S, CH2, H and OH, C1-4 alkenyl, or = N - R14, where R14 is OH, CN, COOH, halogen, formyl, C1-6 acyl, C1-6 alkyl, C1-6 alkoxy, C1-6 halogenated alkyl, phenyl, or phenyl having C1-3 alkyl or C1-3 alkoxy substitution; each R6 is H or C1-4 alkyl; each R7 is H, OH or C1-4 alkyl; each R8 is H or C1-4 alkyl and is absent when the two indicated carbons are triply bonded; R5 is COOR4; CH2OH; CHO; tetrazole; NHSO2R14; CONHSO2R14 hydroxymethylketone; CN; CON(R7)2; a monocyclic or bicyclic heterocyclic ring containing an acidic hydroxyl group; or COOR15 where R15 is: <CHEM> where each s is  independently 0-3, R6 is as defined above and R16 is (A) a monocyclic or bicyclic heterocyclic radical containing from 3 to 12 nuclear carbon atoms and 1 or 2 N heteroatoms or one N and one S heteroatom, each ring in the heterocyclic radical being formed of 5 or 6 atoms, or (B) W-R17 where W is O, S or NH and R17 contains up to 21 carbon atoms and is (1) a hydrocarbon radical or (2) an acyl radical or an organic acylic or monocyclic carboxylic acid containing not more than 1 heteroatom in the ring;  each of r and q is 0-20 but r + q does not exceed 20; and  p is 0 or 1;  R3 is C1-6 alkyl or C3-6 alkenyl; R9 is C1-6 alkyl, C1-6 alkoxy or (CH2)rR5, where r and R5 are as defined above; and R10 is H, C1-6 alkyl; R4CO- or R4OCH2, where R4 is as defined above.   The compounds are prepared by condensing together two compounds having appropriately substituted benzene rimgs, one of which contains a halogen atom in the chain containing Y and Y min , which removes a hydrogen atom from the ring of the other compound.
Patent NZ-216814-A (NZ)
Title: Arylethanol-hydroxylamines as feedstuff additives
Inventor: INGENDOH A
IPC: C07C239/12
Filed: 1986-07-11
Abstract: Aryl ethanol-hydroxylamines of the formula   <IMAGE>   in which Ar represents aryl or heteroaryl, each of which can optionally be substituted, and R represents alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl or cycloalkyl, each of which can optionally be substituted, or physiologically tolerated salts thereof, exhibit animal growth-promoting properties. Intermediates therefor of the formula   <IMAGE>  with the exception of phenyl and p-bromophenyl, are also new.
Patent NZ-229672-A (NZ)
Title: Amplification and detection of nucleic acid sequences
Inventor: JONES THEODORE
IPC: C12Q1/68
Filed: 1989-06-22
Abstract: The invention is directed to a method for detecting a target nucleic acid sequence. The method may employ both an amplification procedure and a detection procedure. Amplification is accomplished through the use of a plurality of pairs of nucleic acid amplification probes, wherein the member probes of each pair of amplification probes are complementary to each other with at least one hybridizing member of each pair of amplification probes also being complementary to a given portion of the target nucleic acid sequence, which acts as a template. The hybridizing members of each pair of amplification probes hybridize to the target sequence in a contiguous manner, sufficiently adjacent to each other to enable the probes to be joined together to form an amplification product. Once the hybridizing amplification probes are joined, the completed amplification product can be separated by denaturation, and the process repeated, until a sufficient quantity of the target nucleic acid sequence is produced to result in measurable signal in the selected assay. The correctly assembled amplification product serves as a template in a manner similar to that served by the target nucleic acid sequence in the amplification procedure.
Patent NZ-231266-A (NZ)
Title: Diphenyl ether derivatives and pyridine analogues; use as herbicidal compositions
Inventor: CARTWRIGHT DAVID
IPC: A01N31/16
Filed: 1989-11-06
Abstract: A herbicidal compound of formula (I): <CHEM> wherein X is O, S(O)n or NR<a> where R<a> is H or alkyl and n is O, 1 or 2;  R<1> is H or halo;  R<2> is N or CR<3> where R<3> is halo or NO2; R<4> is H, halo, NO2, alkyl, haloalkyl, CN, CO2alkyl, cycloalkyl, phenyl, COalkyl, COphenyl, CHO,OH, NH2, NHCOalkyl or alkoxy  R<5> is H, halo or optionally substituted alkyl;  R<6> is H, halo or optionally substituted alkyl;  provided that at least one of R<5> and R<6> is halo; R<7> is CN, CHO, COOR<8>, CONR<8>R<9>, where R<8> is H, optionally substituted alkyl, alkenyl, alkynyl or aryl and R<9> is a group R<8>, SO2alkyl, NR<1><0>R<1><1> or N<+>R<1><0>R<1><1>R<1><2> Z<-> where Z is an agriculturally acceptable anion e.g. chloride and R<1><0>, R<1><1> and R<1><2> are independently selected from hydrogen and alkyl. Processes for the preparation of these compounds and compositions containing them are also described.
Patent NZ-236931-A (NZ)
Title: Method and sensor for the determination of an enzyme substrate or of an oxidoreductase
Inventor: HOENES JOACHIM
IPC: C10M133/50
Filed: 1991-01-29
Abstract: (A) The determn. of an analyte (I) comprises electrochemical reaction in the presence of an oxido-reductase (II) and a reducible substance (III) which, in the course of the reaction, transfers electrons from (II) to an electrode, thus giving rise to a signal which is a measure of (I). (III) is enzymatically reduced. Oxidn. occurs on the electrode, with the substance produced by this oxidn. being different from the original (III). (B) A substance which is capable of taking up electrons from a (II) to form an electron-rich aromatic amine can be used as an electron carrier between a (II) and an electrode in an electrochemical system. (C) A sensor electrode system for the electrochemical determn. of (I) in which a sample contains at least 2 electrically conducting agents which are isolated from each other and which are each brought into electrical contact with the sample (I) via an electrically conducting surface, so that at least one of these surfaces is in contact with a (II) and a (III) which is capable of transferring electrons between the (II) and the surface. The (III) used is a cpd. which, after redn. by (II) can be oxidised on the surface to give a substance different to the original (III).
Patent NZ-237661-A (NZ)
Title: Growth regulatory proteins (epithelins) their production and diagnostic and therapeutic uses
Inventor: SHOYAB MOHAMMED
IPC: C12N15/18
Filed: 1991-04-03
Abstract: A novel family of growth regulatory proteins termed "epithelins" are described. The epithelins comprise several distinct members sharing significant structural homology. Two members of the epithelin family, epithelin 1 and epithelin 2, have been purified from natural sources. In addition, cDNA and PCR clones encoding mature and precursor epithelins from various chordate sources have been obtained and sequenced, including the complete human, mouse and rat epithelin precursors. The recombinant expression of rat epithelin precursor and mature forms is described. Purified epithelin 1 s a bifunctional growth regulator, capable of stimulating the growth of some cell types while inhibiting the growth of others. Purified epithelin 2 is functionally similar to epithelin 1 with respect to growth inhibitory bioactivity. In contrast, however, epithelin 2 is apparently not capable of eliciting the growth stimulatory activity characteristic of epithelin 1 and, in fact, antagonizes this epithelin 1 activity.
Patent NZ-239954-A (NZ)
Title: Polypeptide containing 6, 17 or 32 amino acids and pharmaceutical compositions
Inventor: SEELIG GAIL F
IPC: C07K16/00
Filed: 1991-09-26
Abstract: PCT No. PCT/US91/06771 Sec. 371 Date Mar. 19, 1993 Sec. 102(e) Date Mar. 19, 1993 PCT Filed Sep. 25, 1991 PCT Pub. No. WO92/06115 PCT Pub. Date Apr. 16, 1992.Novel synthetic polypeptides having amino acid sequences corresponding to the sequence of one or more specific regions of human gamma interferon are provided by this invention. These polypeptides specifically inhibit the binding of human gamma interferon to cellular receptors and the biological activity of such interferon. Antibody antagonists of the binding of human gamma interferon to cellular receptors based Upon the use of the polypeptides as antigens are also provided. Some of these antagonists bind to specific regions of gamma interferon which are believed to be involved in interactions between the intefferon and its receptors. Other antibody antagonists are anti-idiotypic antibodies which appear to compete directly with gamma interferon for binding to the cellular receptors. Also provided are methods for the use of the polypeptides and antibodies as inhibitors of the binding of gamma interferon to its cellular receptors.
Patent NZ-245967-A (NZ)
Title: Diving regulator demand valve with venturi assisted air directing means
Inventor: PREECE KIM
IPC: A62B9/02
Filed: 1990-06-06
Abstract: A regulator for use in underwater breathing comprises a primary housing with a breathing chamber and a demand valve (20) enabling flow of air, upon demand by a user, from an inlet orifice (22) to an output (16) in the valve (20) and then to an outlet (32) in the primary housing and then via a mouthpiece (29) to the lungs of a user. The valve (20) comprises a slidably mounted poppet (21) one end (23) of which is urged against orifice (22) by a biasing spring (25). Movable diaphragm (28) in response to demand for air draws end (23) of the poppet away from the orifice (22) against the force of the biasing spring (25) allowing the flow of air. A concentric sleeve about the valve body may be rotated to adjust the flow of air through the regulator. <IMAGE>
Patent NZ-272945-A (NZ)
Title: Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use
Inventor: TOMLEY FIONA MARGARET
IPC: C07K16/00
Filed: 1995-09-07
Abstract: This invention relates to a novel Eimeria protein with immunogenic properties as well as to DNA sequences encoding these proteins. This protein can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding this protein can be used for the preparation of a vector vaccine against coccidiosis.
Patent NZ-275147-A (NZ)
Title: Cancer therapy involving a viral vector and prodrug system where the vector codes for a nitroreductase that converts the prodrug to a cytotoxic drug
Inventor: CONNORS THOMAS
IPC: A61K31/40
Filed: 1994-11-04
Abstract: PCT No. PCT/GB94/02423 Sec. 371 Date Jul. 1, 1996 Sec. 102(e) Date Jul. 1, 1996 PCT Filed Nov. 4, 1994 PCT Pub. No. WO95/12678 PCT Pub. Date May 11, 1995A system is disclosed which comprises: (i) a viral vector comprising a nucleotide sequence encoding a nitroreductase, which nitroreductase is capable of converting a prodrug into a cytotoxic drug; and (ii) a prodrug capable of being converted into a cytotoxic drug by the nitroreductase encoded by the vector. The disclosed invention also includes methods for killing cancerous and/or non-cancerous cells using the system described above. Included in the invention are methods for killing cells in vitro by introducing a vector encoding a nitroreductase into the cells, and then by providing a prodrug to the cells growing in vitro. Also included are methods in which cancerous and/or non-cancerous cells are killed in vivo in an animal or human by administering the vector and prodrug directly to cells of the animal or human. The invention further includes methods in which cancerous and/or non-cancerous cells are killed in vivo in an animal or human, by introducing a viral vector encoding a nitroreductase into animal or human cells growing in vitro so that the nitroreductase is produced in the cells, administering the cells to an animal or human subject, and then administering a prodrug to the animal or human, where it is converted into a cytotoxic agent in nitroreductase-containing cells of the animal or human.
Patent NZ-289289-A (NZ)
Title: Hydromorphone (4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one) compositions and use thereof
Inventor: MERRIL SONYA
IPC: A61K9/20
Filed: 1995-06-23
Abstract: An oral hydromorphone composition for the management of pain comprising dosage form providing analgesia via the oral route over an extended period of time, comprising a therapeutic composition comprising 1 to 1000mg of hydromorphone; 25 to 500mg of carboxymethylcellulose of 10,000 to 300,000 mw as a polymeric carrier; a binder agent selected from at least one of the 1 to 50mg of poly (vinyl) pyrrolidone of 10,000 to 300,000 mw or 1 to 50mg of hydroxypropylcellulose or hydroxypropylalkylcellulose of 7,500 to 75,000 mw; and 0 to 10 mg of a lubricant.
Patent NZ-299958-A (NZ)
Title: Antagonising endothelial vascular adhesion protein-1 (VAP-1) mediated binding of endothelial cells to lymphocytes using anti-VAP-1-antibodiess
Inventor: JALKANEN SIRPA
IPC: C07K16/18
Filed: 1993-06-09
Abstract: The preparation and use of the compound described for treating diseases that antagonise VAP-1-mediated binding of endothelial cells to lymphocytes, of a VAP-1 binding compound such as inflammation (chronic or acute), arthritis, rheumatoid arthritis, infection, dermatosis, inflammatory bowel disease, and autoimmune diseases.
Patent NZ-332805-A (NZ)
Title: Guardrail comprising elongate metal plate with weakened sections and tension member with washer made up of two separate halves
Inventor: DENMAN OWEN S
IPC: E01F15/14
Filed: 1998-11-13
Abstract: A highway guardrail elongate metal plate 16 has at least one ridge extending along a longitudinal dimension and has a rigidity adapted to deflect an automobile that has left a roadway.  Plate 16 comprises a set of weakened regions 54 extending at least partially across plate 16, oriented obliquely to the longitudinal direction to form an elongated fold region 56 at which plate 16 tends to buckle when subjected to a sufficiently large column load.  Fold region 56 is oriented obliquely to the longitudinal direction.
Patent NZ-502700-A (NZ)
Title: Electrically assisted partial oxidation of light hydrocarbons by oxygen
Inventor: CZERNICHOWSKI M ALBIN
IPC: C07B61/00
Filed: 1998-08-28
Abstract: Process for the conversion of hydrocarbons by partial oxidation with elemental oxygen O2 or by simultaneous reforming with O2 and water vapour H2O, characterized by the fact that one (or several) hydrocarbon(s) mixed with water vapour and/or oxygen is (are) exposed to a gliding electric discharge plasma in a gliding electric arc in order to generate and maintain chemical reactions of partial or total conversion of such mixture into a synthesis gas, the latter being a mixture of hydrogen H2 and carbon monoxide CO; this synthesis gas may be accompanied by unsaturated hydrocarbons produced by the same conversion process.
Patent NZ-505658-A (NZ)
Title: Receiver for digital terrestrial broadcasting
Inventor: AZAKAMI HIROSHI
IPC: H04N5/44
Filed: 1999-11-11
Abstract: A digital terrestrial broadcasting wave receiver of a type freed from problems occurring in a transition period of terrestrial broadcasting wave from analog to digital while receiving digital broadcast assuredly from a channel on request. To attain this object, in a digital terrestrial broadcasting wave receiver (100), a channel initial data storage part (17) previously stores three types of frequencies of a normal frequency, an upper-offset frequency, and a lower-offset frequency assigned to each digital broadcast channel. With a requested channel specified by a user, a front end part (13) operates according to the three frequencies assigned thereto. And then based on an OFDM synchronizing signal provided by an OFDM demodulation part (not shown) in the front end part (13), a frequency in actual use for digital broadcast is determined among the above three frequencies.
Patent NZ-505700-A (NZ)
Title: Apparatus and method for rolling clothes in inverse toroidal rollover path in an automatic washer
Inventor: PINKOWSKI ROBERT J
IPC: D06F37/12
Filed: 2000-07-12
Abstract: Various embodiments are disclosed with an impeller in the bottom of the wash tub oscillating, and clothes in the wash basket moving in an inverse toroidal rollover pattern.